Business Wire
Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic... Read more.
CHICAGO–(BUSINESS WIRE)–CORE Industrial Partners (“CORE”), a manufacturing, industrial technology, industrial services, and consumer products-fo... Read more.
Second quarter demonstrates strong momentum in membership, traffic, and unit volumes Second Quarter Fiscal 2024 Highlights Comparable club sales increased by ... Read more.
RALEIGH, N.C.–(BUSINESS WIRE)–$AAP #AAP–Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America... Read more.
A Hotels & Hospitality payments solution to meet customers where they want to pay LONDON–(BUSINESS WIRE)–DNA Payments, a leading provider of pay... Read more.
Subscription revenue grew 9% year-over-year GAAP operating margin increased 8 percentage points year-over-year Non-GAAP operating margin increased 13 percentage... Read more.
Product revenue of $829.3 million in the second quarter, representing 30% year-over-year growth Net revenue retention rate of 127% 510 customers with trailing 1... Read more.
MEMPHIS, Tenn.–(BUSINESS WIRE)–The annual Danny Thomas Celebrity-Am, held on Aug. 15 during FedEx St. Jude Championship week, welcomed St. Jude Chil... Read more.
DULUTH, Ga.–(BUSINESS WIRE)–Asbury Automotive Group (NYSE: ABG) today rejected false and unfounded allegations by the Federal Trade Commission (FTC)... Read more.
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces an investigation on behalf of Ibotta, Inc. (“Ibotta” or the “Company”... Read more.